| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,425 |
12,072 |
$611K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,739 |
10,446 |
$447K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,515 |
3,261 |
$53K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
589 |
559 |
$40K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,135 |
1,725 |
$39K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
547 |
527 |
$34K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
494 |
473 |
$33K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,070 |
1,888 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,107 |
2,645 |
$27K |
| 80305 |
|
3,125 |
2,359 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
973 |
906 |
$11K |
| Q3014 |
Telehealth originating site facility fee |
917 |
609 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
568 |
353 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
512 |
484 |
$8K |
| 3008F |
|
11,646 |
9,012 |
$6K |
| 3074F |
|
9,584 |
7,515 |
$6K |
| 93923 |
|
207 |
51 |
$5K |
| 3078F |
|
8,086 |
6,434 |
$5K |
| 90686 |
|
601 |
487 |
$4K |
| 95923 |
|
112 |
52 |
$3K |
| 1159F |
|
3,891 |
3,042 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
41 |
40 |
$3K |
| 1160F |
|
1,163 |
999 |
$2K |
| 95924 |
|
106 |
52 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
26 |
26 |
$2K |
| 99381 |
|
18 |
15 |
$1K |
| 3079F |
|
1,327 |
1,054 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
19 |
12 |
$895.09 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13 |
12 |
$863.72 |
| 87807 |
|
88 |
71 |
$646.56 |
| 90474 |
|
74 |
71 |
$621.64 |
| 94010 |
|
32 |
31 |
$582.25 |
| 93040 |
|
180 |
87 |
$555.14 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
367 |
283 |
$545.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
717 |
585 |
$417.95 |
| 81002 |
|
198 |
166 |
$306.32 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
12 |
12 |
$210.97 |
| 83655 |
|
16 |
16 |
$162.30 |
| 3077F |
|
162 |
140 |
$120.00 |
| G0008 |
Administration of influenza virus vaccine |
115 |
96 |
$97.48 |
| 36415 |
Collection of venous blood by venipuncture |
116 |
105 |
$89.88 |
| 3080F |
|
71 |
53 |
$70.00 |
| 85018 |
|
16 |
16 |
$32.52 |
| 36416 |
|
14 |
14 |
$20.10 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
220 |
193 |
$0.00 |
| 90648 |
|
303 |
283 |
$0.00 |
| 90633 |
|
75 |
74 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
479 |
400 |
$0.00 |
| 90681 |
|
74 |
71 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
256 |
218 |
$0.00 |
| 90707 |
|
53 |
51 |
$0.00 |
| 90670 |
|
304 |
288 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
40 |
35 |
$0.00 |
| 3044F |
|
60 |
56 |
$0.00 |
| 1034F |
|
429 |
320 |
$0.00 |
| 1036F |
|
510 |
374 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
84 |
77 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
278 |
235 |
$0.00 |
| 90723 |
|
257 |
241 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
126 |
114 |
$0.00 |
| 90716 |
|
30 |
28 |
$0.00 |